Iridex’s Cyclo G6 glaucoma laser approved in South Korea

South Korea’s Ministry of Food and Drug Safety has approved the Cyclo G6 glaucoma laser system, Iridex announced in a press release.
The Cyclo G6 is available in more than 50 countries to treat patients with a range of glaucoma disease, the release said. It uses Iridex’s MicroPulse technology.
“International expansion in the Asia-Pacific region remains a top priority for us, and we believe that Korea represents an attractive market for our G6 technology,” President and CEO of Iridex William M. Moore said in the release.

Full Story →